Chemistry:Cioteronel
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | CPC-10997; Cyoctol; X-Andron |
| Routes of administration | By mouth, topical |
| Drug class | Nonsteroidal antiandrogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H28O2 |
| Molar mass | 252.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cioteronel (INN, USAN) (developmental code name CPC-10997; former tentative brand names Cyoctol, X-Andron) is a nonsteroidal antiandrogen (NSAA) that was never marketed.[1][2][3] It was under development between 1989 and 2001 for the topical treatment of androgenetic alopecia (male pattern baldness), and acne and for the oral treatment of benign prostatic hyperplasia; it reached phase III clinical trials for acne and phase II studies for androgenetic alopecia, but was ultimately discontinued due to poor efficacy.[3][4]
See also
References
- ↑ Dictionary of Pharmacological Agents. CRC Press. 21 November 1996. p. 570. ISBN 978-0-412-46630-4. https://books.google.com/books?id=Z_mfTTIApVEC&pg=PA570.
- ↑ Lednicer, Daniel (21 November 1994). The Organic Chemistry of Drug Synthesis. John Wiley & Sons. pp. 11–. ISBN 978-0-471-58959-4. https://books.google.com/books?id=Os_OQxrXYPcC&pg=PA11.
- ↑ 3.0 3.1 "Benign prostatic hyperplasia: an insight into current investigational medical therapies". Expert Opinion on Investigational Drugs 14 (11): 1359–72. November 2005. doi:10.1517/13543784.14.11.1359. PMID 16255676.
- ↑ "Cioteronel". Adis Insight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800003205.
 |  |
